Castel V - Search Results

1

Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration.

Berbegall AP, Villamón E, Tadeo I, Martinsson T, Cañete A, Castel V, Navarro S, Noguera R. Berbegall AP, et al. Among authors: castel v. Neoplasia. 2014 Jun;16(6):471-80. doi: 10.1016/j.neo.2014.05.012. Neoplasia. 2014. PMID: 25077701 Free PMC article.

2

The role of surgery in stage IV neuroblastoma.

Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, Ruiz-Jimenez JI, Perez-Hernández R, Cañete A. Castel V, et al. J Pediatr Surg. 2002 Nov;37(11):1574-8. doi: 10.1053/jpsu.2002.36187. J Pediatr Surg. 2002. PMID: 12407542 Clinical Trial.

3

Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors.

del Carmen Mejía M, Navarro S, Pellín A, Ruíz A, Castel V, Llombart-Bosch A. del Carmen Mejía M, et al. Among authors: castel v. Arch Med Res. 2002 Sep-Oct;33(5):466-72. doi: 10.1016/s0188-4409(02)00384-3. Arch Med Res. 2002. PMID: 12459317

4

Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.

Mejía C, Navarro S, Pellín A, Ruíz A, Castel V, Llombart-Bosch A. Mejía C, et al. Among authors: castel v. Oncol Rep. 2003 Jan-Feb;10(1):243-7. Oncol Rep. 2003. PMID: 12469176

5

MYCN gain and MYCN amplification in a stage 4S neuroblastoma.

Noguera R, Cañete A, Pellín A, Ruiz A, Tasso M, Navarro S, Castel V, Llombart-Bosch A. Noguera R, et al. Among authors: castel v. Cancer Genet Cytogenet. 2003 Jan 15;140(2):157-61. doi: 10.1016/s0165-4608(02)00677-5. Cancer Genet Cytogenet. 2003. PMID: 12645655

6

A comparison of current neuroblastoma chemotherapeutics.

Castel V, Cañete A. Castel V, et al. Expert Opin Pharmacother. 2004 Jan;5(1):71-80. doi: 10.1517/14656566.5.1.71. Expert Opin Pharmacother. 2004. PMID: 14680437 Review.

7

The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma.

Oltra S, Martinez F, Orellana C, Grau E, Fernandez JM, Cañete A, Castel V. Oltra S, et al. Among authors: castel v. Diagn Mol Pathol. 2005 Mar;14(1):53-7. doi: 10.1097/01.pas.0000149876.32376.c0. Diagn Mol Pathol. 2005. PMID: 15714065 Clinical Trial.

8

[Neuroblastoma].

Castel V, Cañete A, Noguera R, Navarro S, Oltra S; Grupo Español de Neuroblastoma (SEOP). Castel V, et al. Clin Transl Oncol. 2005 Apr;7(3):133-45. doi: 10.1007/BF02708748. Clin Transl Oncol. 2005. PMID: 15899223 Review. Spanish. No abstract available.

9

Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.

Burgues O, Navarro S, Noguera R, Pellín A, Ruiz A, Castel V, Llombart-Bosch A. Burgues O, et al. Among authors: castel v. Virchows Arch. 2006 Oct;449(4):410-20. doi: 10.1007/s00428-006-0253-y. Epub 2006 Aug 29. Virchows Arch. 2006. PMID: 16941154

10

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.

Grau E, Oltra S, Martínez F, Orellana C, Cañete A, Fernández JM, Hernández-Martí M, Castel V. Grau E, et al. Among authors: castel v. J Cancer Res Clin Oncol. 2009 Apr;135(4):523-31. doi: 10.1007/s00432-008-0484-1. Epub 2008 Sep 27. J Cancer Res Clin Oncol. 2009. PMID: 18820946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters